294 related articles for article (PubMed ID: 35583360)
1. Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development.
Lorenzo MM; Nogales A; Chiem K; Blasco R; Martínez-Sobrido L
Microbiol Spectr; 2022 Jun; 10(3):e0027222. PubMed ID: 35583360
[TBL] [Abstract][Full Text] [Related]
2. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L
J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652
[TBL] [Abstract][Full Text] [Related]
3. Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development.
Nogales A; Baker SF; Ortiz-Riaño E; Dewhurst S; Topham DJ; Martínez-Sobrido L
J Virol; 2014 Sep; 88(18):10525-40. PubMed ID: 24965472
[TBL] [Abstract][Full Text] [Related]
4. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661
[TBL] [Abstract][Full Text] [Related]
5. Bi-Reporter Vaccinia Virus for Tracking Viral Infections
Chiem K; Lorenzo MM; Rangel-Moreno J; Garcia-Hernandez ML; Park JG; Nogales A; Blasco R; Martínez-Sobrido L
Microbiol Spectr; 2021 Dec; 9(3):e0160121. PubMed ID: 34817228
[TBL] [Abstract][Full Text] [Related]
6. Protection of mice against the highly pathogenic VV
Bissa M; Quaglino E; Zanotto C; Illiano E; Rolih V; Pacchioni S; Cavallo F; De Giuli Morghen C; Radaelli A
Antiviral Res; 2016 Oct; 134():182-191. PubMed ID: 27637905
[TBL] [Abstract][Full Text] [Related]
7. Human cytotoxic CD4+ T cells recognize HLA-DR1-restricted epitopes on vaccinia virus proteins A24R and D1R conserved among poxviruses.
Mitra-Kaushik S; Cruz J; Stern LJ; Ennis FA; Terajima M
J Immunol; 2007 Jul; 179(2):1303-12. PubMed ID: 17617623
[TBL] [Abstract][Full Text] [Related]
8. Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases.
Perdiguero B; Pérez P; Marcos-Villar L; Albericio G; Astorgano D; Álvarez E; Sin L; Gómez CE; García-Arriaza J; Esteban M
J Mol Biol; 2023 Aug; 435(15):168173. PubMed ID: 37301278
[TBL] [Abstract][Full Text] [Related]
9. Advances in vaccinia virus-based vaccine vectors, with applications in flavivirus vaccine development.
Xie L; Li Y
Vaccine; 2022 Nov; 40(49):7022-7031. PubMed ID: 36319490
[TBL] [Abstract][Full Text] [Related]
10. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
Taylor J; Paoletti E
Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
[TBL] [Abstract][Full Text] [Related]
11. Poxvirus-based vectors as vaccine candidates.
Tartaglia J; Pincus S; Paoletti E
Crit Rev Immunol; 1990; 10(1):13-30. PubMed ID: 2407263
[TBL] [Abstract][Full Text] [Related]
12. Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain.
Bissa M; Pacchioni SM; Zanotto C; De Giuli Morghen C; Illiano E; Granucci F; Zanoni I; Broggi A; Radaelli A
Virus Res; 2013 Dec; 178(2):374-82. PubMed ID: 24050999
[TBL] [Abstract][Full Text] [Related]
13. L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines.
Pacchioni SM; Bissa M; Zanotto C; Morghen Cde G; Illiano E; Radaelli A
J Transl Med; 2013 Apr; 11():95. PubMed ID: 23578094
[TBL] [Abstract][Full Text] [Related]
14. Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes.
Legrand FA; Verardi PH; Jones LA; Chan KS; Peng Y; Yilma TD
J Virol; 2004 Mar; 78(6):2770-9. PubMed ID: 14990697
[TBL] [Abstract][Full Text] [Related]
15. Clinical development of Modified Vaccinia virus Ankara vaccines.
Gilbert SC
Vaccine; 2013 Sep; 31(39):4241-6. PubMed ID: 23523410
[TBL] [Abstract][Full Text] [Related]
16. Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins.
Wyatt LS; Xiao W; Americo JL; Earl PL; Moss B
mBio; 2017 Jun; 8(3):. PubMed ID: 28588133
[TBL] [Abstract][Full Text] [Related]
17. Poxviruses as vaccine vectors.
Pastoret PP; Vanderplasschen A
Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):343-55. PubMed ID: 12818621
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of Human Respiratory Viruses by Synonymous Genome Recoding.
Le Nouën C; Collins PL; Buchholz UJ
Front Immunol; 2019; 10():1250. PubMed ID: 31231383
[TBL] [Abstract][Full Text] [Related]
19. A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene.
Cai Y; Ye C; Cheng B; Nogales A; Iwasaki M; Yu S; Cooper K; Liu DX; Hart R; Adams R; Brady T; Postnikova EN; Kurtz J; St Claire M; Kuhn JH; de la Torre JC; Martínez-Sobrido L
mBio; 2020 Feb; 11(1):. PubMed ID: 32098811
[TBL] [Abstract][Full Text] [Related]
20. A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication.
Verardi PH; Titong A; Hagen CJ
Hum Vaccin Immunother; 2012 Jul; 8(7):961-70. PubMed ID: 22777090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
